Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Enlarged Prostate

Statins may delay prostate problems in older men

Taking statins for high cholesterol appears to significantly delay the development of an enlarged prostate, a common condition in older men that can lead to incontinence and other distressing symptoms, researchers at the Mayo Clinic report.

An estimated 40 percent of older men develop prostate enlargement and trouble urinating at some point.

Cholesterol levels… Statins may delay prostate problems in older men   



Issues seen with drugs to curb prostate cancer: FDA

U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain men.

Both drugs are already approved to treat symptoms in men with enlarged prostate, but GlaxoSmithKline Plc is seeking a wider approval to… Issues seen with drugs to curb prostate cancer: FDA   



Doctors Issue New Guidelines on Spotting, Treating Enlarged Prostate

Experts at the American Urological Association (AUA) have issued updated guidelines on diagnosing and treating enlarged prostate—a common condition formally know as benign prostatic hyperplasia (BPH).

BPH can lead to lower urinary tract symptoms such as incontinence and affect a man’s quality of life. The new guidelines, the first since 2003, include a detailed… Doctors Issue New Guidelines on Spotting, Treating Enlarged Prostate   



Surgery or radiation, not monitoring, most often sought for low-risk prostate cancer, Mayo finds

Few physicians recommend active surveillance for low-risk prostate cancer rather than pursuing surgery or radiation, according to a Mayo Clinic study being presented at the North Central Section of the American Urological Association’s annual meeting Oct. 10 in Chicago. Mayo Clinic urologists also are discussing findings on enlarged prostates, bladder cancer and other research… Surgery or radiation, not monitoring, most often sought for low-risk prostate cancer, Mayo finds   



antioxidant1 - attention deficit hyperactivity disorder1 - extracorporeal shockwave lithotripsy1 - journal of urology5 - rituximab1 - uds5 - uterus2 - anti-androgen therapy1 - kidney stone2 - urinary tract imaging1 - robotic-assisted cystectomy1 - gfr1 - dstyk1 - halpin foundation1 - obstructive pyelonephritis1 - sexually transmitted infections1 - male sex hormones1 - kidney failure37 - clinical nephrology conference1 - kidney disease complications1 - fox chase cancer center2 - methotrexate1 - prostate cancers1 - severe urinary incontinence1 - scientific registry of transplant recipients1 - peritonitis1 - human vaccine1 - urinary tract problems1 - persistent incontinence1 - cardiovascular disease5 -